✦ LIBER ✦

Low to moderate cumulative doses of pegylated liposomal doxorubicin in the treatment of classic Kaposi sarcoma in elderly patients with comorbidities

✍ Scribed by I. Potouridou; C. Korfitis; D. Ioannidou; D. Polydorou; N. Zakopoulou; A.J. Stratigos; A.D. Katsambas

Book ID: 108669828
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 59 KB
Volume: 158
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.2007.08345.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin as secon

Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma : A retrospective study

✍ Giuseppe Di Lorenzo; Rossella Di Trolio; Vincenzo Montesarchio; Giovanna Palmier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND. Classic Kaposi sarcoma (CKS) is a rare neoplasm that predominantly occurs in elderly subjects and has a variable clinical evolution. The clinical course is usually indolent, but occasionally the neoplasm progresses rapidly and spreads to internal organs, necessitating sy

Activity and Safety of Pegylated Liposom

Activity and Safety of Pegylated Liposomal Doxorubicin as First-Line Therapy in the Treatment of Non-Visceral Classic Kaposi's Sarcoma: A Multicenter Study

✍ Di Lorenzo, Giuseppe; Kreuter, Alexander; Di Trolio, Rossella; Guarini, Attilio; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB